Royal Bank Of Canada Viking Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 395,893 shares of VKTX stock, worth $16.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

395,893

Previous 266,883 48.34%

Holding current value

$16.8 Million

Previous $14.1 Million 77.16%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $6.43 Million - $9.09 Million	129,010 Added 48.34%	395,893 $25.1 Million
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $6.66 Million - $11.3 Million	140,491 Added 111.15%	266,883 $14.1 Million
Q1 2024 Nov 05, 2024	SELL	$17.4 - $94.5 $2.44 Million - $13.3 Million	-140,491 Reduced 52.64%	126,392 $10.4 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $967,892 - $5.26 Million	55,626 Added 78.61%	126,392 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $536,890 - $1.14 Million	58,105 Added 458.93%	70,766 $1.32 Million
Q3 2023 Nov 14, 2023	SELL	$10.92 - $16.0 $25,323 - $37,104	-2,319 Reduced 15.48%	12,661 $140,000
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $207,433 - $346,514	13,978 Added 1395.01%	14,980 $242,000
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $3,248 - $6,966	402 Added 67.0%	1,002 $16,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $772 - $2,669	284 Added 89.87%	600 $5,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $3.89 $550 - $840	216 Added 216.0%	316 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $8,657 - $12,924	-4,103 Reduced 97.62%	100 $0
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $49,698 - $80,842	-16,566 Reduced 79.76%	4,203 $13,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $167,435 - $244,601	-36,399 Reduced 63.67%	20,769 $95,000
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $32,553 - $41,071	5,834 Added 11.36%	57,168 $359,000
Q2 2021 Aug 16, 2021	BUY	$5.19 - $6.73 $266,423 - $345,477	51,334 New	51,334 $307,000

Others Institutions Holding VKTX

# of Institutions

474

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.26B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Viking Therapeutics, Inc. Transaction History